Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Ticker: AEHR
Current Price: ~$11.32
Market Cap: ~$337 million
Industry: Semiconductor Test Equipment
Aehr provides specialized test and burn-in systems for high-demand semiconductor sectors, including silicon carbide (SiC) used in EVs and power electronics. Its proprietary FOX-XP and FOX-P wafer-level systems support wafer-level testing — a critical bottleneck in SiC and 300 mm chip production. As semiconductor demand surges, AEHR offers recurring equipment sales. Profitability and cash flow have returned in 2023 and are strengthening into 2025, positioning it as a potential value opportunity with industry tailwinds.
Growth driven by SiC demand (EVs, renewables, power electronics) and 300 mm wafer testing.
AEHR’s systems support multiple steps in the wafer lifecycle, making it a potential choke-point vendor.
Even a small market share in the SiC test space (~$1–2B TAM) could suggest meaningful multi-year revenue potential.
Metric | Q1–Q3 2024 / TTM |
---|---|
Revenue | ~$61.5 million |
Net Income | ~$22.85 million (37.2% margin) |
EPS | ~$0.78 |
Gross Margin | 45.7% |
Cash (as of latest) | ~$29.4 million |
Debt | ~$6.4 million |
Net Cash | ~$22.97 million |
With ~$1.2 per share net cash and improving margins, AEHR trades near a ~15× forward earnings multiple — a valuation that may be reasonable when considering strong profitability.
Assuming:
Estimated EPS growth from ~$0.78 (TTM) to ~$1.60 by mid-2026 (CAGR ~45%)
Forward P/E at current price = 11.32 ÷ 1.6 ≈ 7.1
Forward PEG = 7.1 ÷ 45 ≈ 0.16
A PEG well below 1 and nearing 0.2 may suggest favorable valuation characteristics for a high-margin, growth-accretive hardware player.
Implication: High short interest in a low-medium cap stock could contribute to price volatility under certain conditions.
The average target implies limited near-term upside (~5%), but upside to $25 (~120%) on execution raises speculative opportunity meaningfully.
Risk | Mitigant |
---|---|
Semiconductor cyclicality risk | Serving diverse segments (SiC, logic, photonics) |
Supply chain / execution delays | Modular system sales across multiple end markets |
Extended valuation drag | Strong profitability and high cash buffer stabilize outlook |
Aehr Test is a rare public micro-cap hardware value play with real earnings, cash flow, and strong margins. Trading at ~15× forward EPS with net cash and forecast earnings growth (45% CAGR), and supported by PEG of ~0.16, it may be undervalued given its niche strength in critical semiconductor infrastructure. Elevated short interest adds volatility and optionality.
This company may interest investors looking for near-term cash flow and long-term growth exposure in semiconductor test equipment.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. The author is not a registered investment advisor. All opinions are the author’s own. Readers are encouraged to do their own research and consult with a licensed financial professional before making investment decisions.